J. Leech

The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

A. Konstas, W. C. Stewart, V. Kozobolis, 2002, Eye.

Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.

J. A. Stewart, M. Krajewska, W. C. Stewart, 2003, Acta ophthalmologica Scandinavica.

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.

W. C. Stewart, A. Kolker, J. Leech, 2003, American journal of ophthalmology.

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.

A. Konstas, W. C. Stewart, E. Nakos, 2002, American journal of ophthalmology.

Factors associated with long-term progression or stability in primary open-angle glaucoma.

W C Stewart, M. Johnson, W. C. Stewart, 2000, American journal of ophthalmology.

An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.

W. C. Stewart, E. Sharpe, J. Leech, 2002, The American journal of managed care.

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.

G. Schwartz, W. C. Stewart, K. T. Holmes, 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

P. Schacknow, W. C. Stewart, E. Sharpe, 2003, American journal of ophthalmology.

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate.

W. C. Stewart, K. T. Holmes, J. Leech, 2000, American journal of ophthalmology.